(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 38937.40 | 37345.90 | 4.26 | 157906.00 | 153808.20 | 2.66 | 157906.00 | 153808.20 | 2.66 |
| Other Income | 1197.10 | 3163.10 | -62.15 | 4567.90 | 6667.00 | -31.48 | 4567.90 | 6667.00 | -31.48 |
| PBIDT | 9194.90 | 9415.70 | -2.35 | 42493.70 | 43779.30 | -2.94 | 42493.70 | 43779.30 | -2.94 |
| Interest | 104.60 | 57.80 | 80.97 | 270.20 | 269.30 | 0.33 | 270.20 | 269.30 | 0.33 |
| PBDT | 7231.30 | 9357.90 | -22.73 | 40364.50 | 43510.00 | -7.23 | 40364.50 | 43510.00 | -7.23 |
| Depreciation | 1615.80 | 1367.20 | 18.18 | 5959.10 | 5466.20 | 9.02 | 5959.10 | 5466.20 | 9.02 |
| PBT | 5615.50 | 7990.70 | -29.72 | 34405.40 | 38043.80 | -9.56 | 34405.40 | 38043.80 | -9.56 |
| TAX | 2060.60 | 1598.60 | 28.90 | 9710.10 | 9218.00 | 5.34 | 9710.10 | 9218.00 | 5.34 |
| Deferred Tax | -385.80 | -0.50 | 77060.00 | -400.90 | -276.90 | 44.78 | -400.90 | -276.90 | 44.78 |
| PAT | 3554.90 | 6392.10 | -44.39 | 24695.30 | 28825.80 | -14.33 | 24695.30 | 28825.80 | -14.33 |
| Equity | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 |
| PBIDTM(%) | 23.61 | 25.21 | -6.34 | 26.91 | 28.46 | -5.46 | 26.91 | 28.46 | -5.46 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: